EMEND 125 mg, hard capsule and emend 80 mg, hard capsule capsule, parallel import (BB FARMA)
Active ingredients: Aprepitant
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Hard capsulecapsule, parallel import (BB FARMA)orale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- EMEND 125 mg, gélule et EMEND 80 mg, gélule
- Pharmaceutical form
- gélule et gélule
- Route of administration
- orale
- Presentation description
- plaquette aluminium de 1 gélule de 125 mg et de 2 gélule(s) de 80 mg (Distributeur parallèle : BB FARMA)
- Marketing authorisation holder
- MERCK SHARP & DOHME (PAYS-BAS)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 7 Sept 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66824150CIP74950083CIP133400949500833Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| APRÉPITANTgélule blanche | 80 mg · une gélule | SA |
| APRÉPITANTgélule blanche et rose | 125 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.